Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the appointment of Adrian Bot, M.D.
Scientists unveil penny-sized microrobots that swim, sense temperature, and run for months using light-powered brains.